ProfileGDS4718 / 225533_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 75% 66% 84% 74% 66% 83% 75% 71% 67% 75% 70% 71% 77% 78% 76% 73% 73% 78% 76% 87% 77% 76% 71% 71% 75% 81% 61% 75% 75% 76% 79% 76% 67% 69% 77% 77% 81% 73% 69% 82% 68% 82% 78% 80% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.303575
GSM549102patient 115, normal, homogenized [OPG study]6.5592366
GSM549104patient 119, normal, homogenized [OPG study]8.4403284
GSM549108patient 138, normal, homogenized [OPG study]7.1469674
GSM549119patient 077, normal, homogenized [OPG study]6.5274966
GSM549133patient 032, cancer, homogenized [OPG study]8.3317383
GSM549139patient 042, cancer, homogenized [OPG study]7.3915975
GSM549099patient 107, normal, homogenized [OPG study]6.9313271
GSM549109patient 139, normal, homogenized [OPG study]6.6443267
GSM549110patient 046, normal, homogenized [OPG study]7.2666775
GSM549114patient 063, normal, homogenized [OPG study]6.8473670
GSM549122patient 082, normal, homogenized [OPG study]6.9921971
GSM549134patient 033, cancer, homogenized [OPG study]7.5338377
GSM549136patient 036, cancer, homogenized [OPG study]7.6929178
GSM549140patient 044, cancer, homogenized [OPG study]7.5111176
GSM549111patient 047, normal, homogenized [OPG study]7.1467473
GSM549113patient 057, normal, homogenized [OPG study]7.1384373
GSM549132patient 031, cancer, homogenized [OPG study]7.6837378
GSM549137patient 038, cancer, homogenized [OPG study]7.4714876
GSM549142patient 047, cancer, homogenized [OPG study]8.3577987
GSM549100patient 110, normal, homogenized [OPG study]7.4227977
GSM549107patient 135, normal, homogenized [OPG study]7.4697476
GSM549115patient 068, normal, homogenized [OPG study]6.9800171
GSM549116patient 072, normal, homogenized [OPG study]6.968171
GSM549120patient 078, normal, homogenized [OPG study]7.2913875
GSM549131patient 030, cancer, homogenized [OPG study]8.0971681
GSM549118patient 074, normal, homogenized [OPG study]6.2258761
GSM549129patient 027, cancer, homogenized [OPG study]7.3900675
GSM549123patient 088, normal, homogenized [OPG study]7.3474875
GSM549124patient 006, cancer, homogenized [OPG study]7.3552476
GSM549126patient 015, cancer, homogenized [OPG study]7.7462379
GSM549128patient 025, cancer, homogenized [OPG study]7.4928576
GSM549103patient 117, normal, homogenized [OPG study]6.6132367
GSM549117patient 073, normal, homogenized [OPG study]6.747169
GSM549138patient 041, cancer, homogenized [OPG study]7.5324677
GSM549141patient 045, cancer, homogenized [OPG study]7.7058777
GSM549130patient 028, cancer, homogenized [OPG study]7.9141681
GSM549101patient 111, normal, homogenized [OPG study]7.1092173
GSM549105patient 128, normal, homogenized [OPG study]6.802969
GSM549106patient 134, normal, homogenized [OPG study]8.2431782
GSM549112patient 048, normal, homogenized [OPG study]6.7195468
GSM549125patient 011, cancer, homogenized [OPG study]8.0594782
GSM549127patient 024, cancer, homogenized [OPG study]7.716778
GSM549135patient 035, cancer, homogenized [OPG study]8.0054180